Back to top

Image: Bigstock

Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2%

Read MoreHide Full Article

Catalyst Pharmaceuticals, Inc. (CPRX - Free Report) was a big mover last session, as its shares rose over 18% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.  This continues the recent uptrend for the company as the stock is now up almost 78% in the past one-month time frame.

The company has seen a mixed track record when it comes to estimate revisions of one increase and two decreases over the past 30 days, while the Zacks Consensus Estimate remained unchanged. Yesterdays’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Catalyst Pharmaceuticals currently carries a Zacks Rank #3 (Hold).

A better-ranked stock in the Medical - Drugs space is Grifols, S.A. (GRFS - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is CPRX going up? Or down? Predict to see what others think: Up or Down
    
More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere
1 billion iPhones in 10 years but a new breakthrough is expected to generate more
than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging
phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020. Click here for the 6 trades >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Catalyst Pharmaceuticals, Inc. (CPRX) - free report >>

Grifols, S.A. (GRFS) - free report >>

Published in